Citadel Advisors’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $311K | Buy |
+58,761
| New | +$311K | ﹤0.01% | 4577 |
|
|
2025
Q1 | – | Sell |
-16,319
| Closed | -$209K | – | 6754 |
|
|
2024
Q4 | $209K | Sell |
16,319
-14,563
| -47% | -$186K | ﹤0.01% | 4856 |
|
|
2024
Q3 | $331K | Buy |
30,882
+5,981
| +24% | +$64.1K | ﹤0.01% | 4190 |
|
|
2024
Q2 | $197K | Buy |
24,901
+7,171
| +40% | +$56.8K | ﹤0.01% | 4681 |
|
|
2024
Q1 | $284K | Buy |
17,730
+14,367
| +427% | +$230K | ﹤0.01% | 4450 |
|
|
2023
Q4 | $46.1K | Sell |
3,363
-13,768
| -80% | -$189K | ﹤0.01% | 5148 |
|
|
2023
Q3 | $250K | Buy |
17,131
+12,596
| +278% | +$184K | ﹤0.01% | 4396 |
|
|
2023
Q2 | $77.1K | Sell |
4,535
-104,204
| -96% | -$1.77M | ﹤0.01% | 4852 |
|
|
2023
Q1 | $1.52M | Buy |
108,739
+66,507
| +157% | +$929K | ﹤0.01% | 2779 |
|
|
2022
Q4 | $279K | Buy |
42,232
+16,721
| +66% | +$110K | ﹤0.01% | 4402 |
|
|
2022
Q3 | $135K | Sell |
25,511
-61,628
| -71% | -$326K | ﹤0.01% | 5010 |
|
|
2022
Q2 | $414K | Buy |
+87,139
| New | +$414K | ﹤0.01% | 4329 |
|
|
2022
Q1 | – | Sell |
-13,628
| Closed | -$163K | – | 6974 |
|
|
2021
Q4 | $163K | Buy |
+13,628
| New | +$163K | ﹤0.01% | 5615 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6960 |
|
|
2021
Q2 | – | Sell |
-56,562
| Closed | -$1.12M | – | 6964 |
|
|
2021
Q1 | $1.12M | Buy |
56,562
+25,304
| +81% | +$501K | ﹤0.01% | 3811 |
|
|
2020
Q4 | $581K | Buy |
31,258
+9,660
| +45% | +$180K | ﹤0.01% | 3738 |
|
|
2020
Q3 | $544K | Buy |
+21,598
| New | +$544K | ﹤0.01% | 3422 |
|
|
2020
Q1 | – | Sell |
-8,510
| Closed | -$387K | – | 5210 |
|
|
2019
Q4 | $387K | Buy |
+8,510
| New | +$387K | ﹤0.01% | 3707 |
|